Sciclips's Blog

Highlights of US patent applications published on September 29, 2011:

1. Biomarker for predicting increased risk of coronary heart disease (CHD) in patients with type 2 diabetes.
2. Diagnostic biomarker for brain disease caused by brain injury .
3. Gene expression biomarkers for the diagnosis and prognosis of prostate cancer patients.
4. Total FVII protein as a biomarker of pre-eclampsia.
5. Biomarkers of IgA nephropathy or TGBM nephropathy.
6. Serum biomarker panel for the diagnosis of Alzheimer’s disease.
7. PSA glycans as biomarkers for the diagnosis of prostate cancer.
8. Exosomal biomarkers for the diagnosis of prostate cancer and colon cancer.
9. Biomarkers for the diagnosis of exposure to electromagnetic radiation.
10. Phage microarrays for the diagnosis of prostate cancer.
11. LTBP2 as a biomarker of renal dysfunction.
12. LTBP2 as predictive marker for mortality in patients with acute dyspnea.
13. NMR based diagnosis of asthma, COPD and other respiratory diseases using metabolomic biomarkers.
14. Predicting chemotherapy outcome for individualized cancer treatment.
15. MicroRNA biomarkers for the diagnosis of motor neuron diseases.
16. Protein polymorphism biomarkers in human hair for paternity testing and forensic analysis.
Details: http://www.sciclips.com/sciclips/biomarker-news.do

Related blogs:

1. Cancer Theranostics – Potential Applications of Cancer Biomarker Database
2. Are stem cells ready as a next generation drug discovery tool?
3. Cell based reporter assays: misleading approach in drug discovery?

Related tools:

1. Drug discovery protocols
2. Bioprotocols
3. Drug discovery reagents
4. Drug discovery news
5. Comprehensive cancer biomarker database with companion diagnostics pathway